Treatment Effectiveness with Venetoclax-Based Therapy after Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: an International Real-World Study Nilanjan Ghosh , Toby A. Eyre , Jennifer R. Brown , Nicole Lamanna , Beenish S. Manzoor , Catherine C. Coombs , Hande H. Tuncer , Chaitra Ujjani , Lori A. Leslie , Lindsey E. Roeker , Matthew S. Davids , Joanna M. Rhodes , Alan P. Skarbnik , Wendy Sinai , Isabelle Fleury , Brian T. Hill , Nicolas Martinez-Calle , Paul M. Barr , Dureshahwar Jawaid , Nnadozie Emechebe , Laurie Pearson , Frederick Lansigan , Yun Choi , Christopher E. Jensen , Bita Fakhri , Deborah M. Stephens , Steven E. Marx , Stephen J. Schuster , Michael Coyle , Irina Pivneva , Talissa Watson , Annie Guerin , Mazyar Shadman AMERICAN JOURNAL OF HEMATOLOGY（2025）
关键词
Bruton tyrosine kinase inhibitor, chronic lymphocytic leukemia, real-world outcomes, venetoclax
AI 理解论文
溯源树
样例
